The company attributes the falling revenue to fewer sales of the surgical system in the U.S., as well as a revenue deferral from allowing customers to trade in older models of da Vinci Si Surgical Systems for the newly approved da Vinci Xi. This referral program reduced first quarter revenue by approximately $26 million, according to the news release.
During the first quarter of 2014, Surgical Intuitive shipped 87 surgical systems, compared to 164 during the first quarter of 2013. Contributing factors to the decline in system sales include fewer procedures, a shift in spending priorities due to the Affordable Care Act and expecting a newer version of the surgical system, according to the news release.
More Articles on da Vinci Surgical Systems:
FDA Clears Intuitive Surgical’s Latest da Vinci Robot Upgrade
Paul Levy: Hospital’s Questionable da Vinci Robot Ad Should Get Someone Fired
Da Vinci Robots: Minimally Invasive Miracle or Costly Conundrum?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
